(Q50124857)
Statements
1 reference
Safety and tolerance of palivizumab administration in a large Northern Hemisphere trial. Northern Hemisphere Expanded Access Study Group. (English)
1 reference
Groothuis JR
1 reference
1 June 2001
1 reference
20
1 reference
6
1 reference
628-630
1 reference